Reducing unnecessary biopsy during prostate cancer screening using a four-Kallikrein panel: An independent replication Academic Article uri icon

Overview

MeSH Major

  • Kallikreins
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • We have replicated our previously published finding that a panel of four kallikreins can predict the result of biopsy for prostate cancer in men with elevated PSA. Use of this panel would dramatically reduce biopsy rates. A small number of men with cancer would be advised against immediate biopsy, but these men would have predominately low-stage, low-grade disease.

publication date

  • May 20, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2881727

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.24.1968

PubMed ID

  • 20421547

Additional Document Info

start page

  • 2493

end page

  • 8

volume

  • 28

number

  • 15